Advertisement

Environmental Science and Pollution Research

, Volume 26, Issue 30, pp 31158–31165 | Cite as

Traces of intact paraben molecules in endometrial carcinoma

  • Selen DoganEmail author
  • Timur Tongur
  • Taner Erkaymaz
  • Gulgun Erdogan
  • Betul Unal
  • Bulent Sik
  • Tayup Simsek
Research Article

Abstract

Endometrial carcinoma is the most commonly encountered gynecological cancer in women worldwide and is also one of the popular models of the hormone-dependent carcinomas. This study was aimed to evaluate and compare the concentrations of five paraben molecules (methylparaben, ethylparaben, N-propylparaben, benzylparaben, isobutylparaben + N-butylparaben) in the endometrial and myometrial tissue samples of patients diagnosed with endometrial carcinoma and benign gynecologic diseases. A total of 88 patients were included in the study and chemical analysis was performed on 176 tissue samples. The study group comprised of 33 patients with endometrial carcinoma and 6 patients with endometrial intraepithelial neoplasia. The control group comprised of 49 patients. One endometrial and one myometrial tissue samples were collected from each patient. The analyses were performed using ultrahigh-performance liquid chromatography and tandem mass spectrometry (UHPLC-MS/MS). At least one type of paraben molecule was detected in 23.07% (9/39) of the patients in the study group, and in 2.04% (1/49) of the patients in the control group; this difference between the groups was statistically significant (p = .002). N-Propylparaben and isobutyl + N-butylparaben were the most frequently detected (in 7/10 of the samples) paraben molecules in the study. Tumor characteristics (tumor diameter, myometrial invasion, architectural grade, nuclear grade, lymphovascular space invasion, and tumor stage) were comparable between the two groups of endometrial carcinoma (paraben-detected and paraben-undetected groups). In conclusion, paraben molecules were more frequently detected in the endometrial carcinoma tissue samples than in the normal endometrium.

Keywords

Carcinoma Endometrium Estrogen Hormone structure and function Endocrine-disrupting chemicals Environmental toxicology 

Notes

Author contributions

SD: Methodology, formal analysis and investigation, conceptualization, writing—original draft preparation, writing—review and editing; TT, TE, and BS: Formal analysis and investigation, methodology, validation; GE and BU: Conceptualization; TS: Supervision; All authors: Final approval of the manuscript

Funding information

This study was financially supported by the Coordination Unit, Scientific Research Project Council of the Akdeniz University.

Compliance with ethical standards

This study was approved by the ethical committee of the Akdeniz University. Informed consent from participants was obtained

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Abbas S, Greige-Gerges H, Karam N, Piet MH, Netter P, Magdalou J (2010) Metabolism of parabens (4-hydroxybenzoic acid esters) by hepatic esterases and UDP-glucuronosyltransferases in man. Drug Metab Pharmacokinet (6):568–577CrossRefGoogle Scholar
  2. Barr L, Metaxas G, Harbach CA, Savoy LA, Darbre PD (2012) Measurement of paraben concentrations in human breast tissue at serial locations across the breast from axilla to sternum. J Appl Toxicol 32(3):219–232CrossRefGoogle Scholar
  3. Bethea TN, Wesselink AK, Weuve J, McClean MD, Hauser R, Williams PL, Ye X, Calafat AM, Baird DD, Wise LA (2019) Correlates of exposure to phenols, parabens, and triclocarban in the Study of Environment. J Expo Sci Environ Epidemiol.  https://doi.org/10.1038/s41370-019-0114-9
  4. Boberg J, Taxvig C, Christiansen S, Hass U (2010) Possible endocrine disrupting effects of parabens and their metabolites. Reprod Toxicol 30(2):301–312CrossRefGoogle Scholar
  5. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1):10–17CrossRefGoogle Scholar
  6. Caldon CE, Sutherland RL, Musgrove E (2010) Cell cycle proteins in epithelial cell differentiation: implications for breast cancer. Cell Cycle 9(10):1918–1928CrossRefGoogle Scholar
  7. Charles AK, Darbre PD (2013) Combinations of parabens at concentrations measured in human breast tissue can increase proliferation of MCF–7 human breast cancer cells. J Appl Toxicol 33(5):390–398CrossRefGoogle Scholar
  8. Choi J, Knudsen LE, Mizrak S, Joas A (2017) Identification of exposure to environmental chemicals in children and older adults using human biomonitoring data sorted by age: results from a literature review. Int J Hyg Environ Health 220(2 Pt A):282–298CrossRefGoogle Scholar
  9. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS (2004) Concentrations of parabens in human breast tumours. J Appl Toxicol 24(1):5–13CrossRefGoogle Scholar
  10. Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR (2011) Trends in endometrial cancer incidence rates in the United States, 1999–2006. J Women's Health (Larchmt) 20(8):1157–1163CrossRefGoogle Scholar
  11. Durando M, Kass L, Piva J, Sonnenschein C, Soto AM, Luque EH, Muñoz-de-Toro M (2007) Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect 115(1):80–86CrossRefGoogle Scholar
  12. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefGoogle Scholar
  13. Golden R, Gandy J, Vollmer G (2005) A review of the endocrine activity of parabens and implications for potential risks to human health. Crit Rev Toxicol 35(5):435–458CrossRefGoogle Scholar
  14. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT (2015) EDC–2: The endocrine society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev 36(6):E1–E150CrossRefGoogle Scholar
  15. Ishiwatari S, Suzuki T, Hitomi T, Yoshino T, Matsukuma S, Tsuji T (2007) Effects of MePB paraben on skin keratinocytes. J Appl Toxicol 27(1):1–9CrossRefGoogle Scholar
  16. Kolatorova L, Sramkova M, Vitku J, Vcelak J, Lischkova O, Starka L, Duskova M (2018) Parabens and their relation to obesity. Physiol Res 67(Supplementum 3):S465–S472CrossRefGoogle Scholar
  17. Mallozzi M., Leone C, Manurita F, Bellati F, Caserta D (2017) Endocrine disrupting chemicals and endometrial cancer: an overview of recent laboratory evidence and epidemiological studies. Int J Environ Res Public Health, 14 (3)CrossRefGoogle Scholar
  18. Mariotto AB, Noone AM, Howlader N, Cho H, Keel GE, Garshell J, Woloshin S, Schwartz LM (2014) Cancer survival: an overview of measures, uses, and interpretation. J Natl Cancer Inst Monogr 49:145–186CrossRefGoogle Scholar
  19. Messerlian C, Mustieles V, Wylie BJ, Ford JB, Keller M, Ye X, Calafat AM, Williams PL, Hauser R (2017) Ultrasound gel as an unrecognized source of exposure to phthalates and phenols among pregnant women undergoing routine scan. Int J Hyg Environ Health 220(8):1285–1294CrossRefGoogle Scholar
  20. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11(8):558–572CrossRefGoogle Scholar
  21. Okubo T, Yokoyama Y, Kano K, Kano I (2001) ER-dependent estrogenic activity of parabens assessed byproliferation of human breast cancer MCF–7 cells and expression of ERalpha and PR. Food Chem Toxicol 39(12):1225–1232CrossRefGoogle Scholar
  22. Pan S, Yuan C, Tagmount A, Rudel RA, Ackerman JM, Yaswen P, Vulpe CD, Leitman DC (2016) Parabens and human epidermal growth factor receptor ligand cross-talk in breast cancer cells. Environ Health Perspect 124(5):563–569CrossRefGoogle Scholar
  23. Pastor-Barriuso R, Fernández MF, Castaño-Vinyals G, Whelan D, Pérez-Gómez B, Llorca J, Villanueva CM, Guevara M, Molina-Molina JM, Artacho-Cordón F, Barriuso-Lapresa L, Tusquets I, Dierssen-Sotos T, Aragonés N, Olea N, Kogevinas M, Pollán M (2016) Total effective xenoestrogen burden in serum samples and risk for breast cancer in a population-based multicase-control study in Spain. Environ Health Perspect 124(10):1575–1582CrossRefGoogle Scholar
  24. Pollock T, Weaver RE, Ghasemi R, deCatanzaro D (2017) Butyl paraben and propyl paraben modulate bisphenol A and estradiol concentrations in female and male mice. Toxicol Appl Pharmacol 325:18–24CrossRefGoogle Scholar
  25. Prusakiewicz JJ, Harville HM, Zhang Y, Ackermann C, Voorman RL (2007) Parabens inhibit human skin estrogen sulfotransferase activity: possible link to paraben estrogenic effects. Toxicology 232(3):248–256CrossRefGoogle Scholar
  26. Purdie DM, Green AC (2001) Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 15(3):341–354CrossRefGoogle Scholar
  27. Rajapakse N, Silva E, Kortenkamp A (2002) Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 110(9):917–921CrossRefGoogle Scholar
  28. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578CrossRefGoogle Scholar
  29. Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP (1998) Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol 153(1):12–19CrossRefGoogle Scholar
  30. Sajid M, Basheer C, Narasimhan K, Choolani M, Lee HK (2015) Application of microwave-assisted micro-solid-phase extraction for determination of parabens in human ovarian cancer tissues. J Chromatogr B Anal Technol Biomed Life Sci 1000:192–198CrossRefGoogle Scholar
  31. Satoh K, Nonaka R, Ohyama K, Nagai K (2005) Androgenic and antiandrogenic effects of alkylphenols and parabens assessed using the reporter gene assay with stably transfected CHO-K1 cells (AR-Eco-Screen System). J Health Sci 51:557–568CrossRefGoogle Scholar
  32. Schug TT, Janesick A, Blumberg B, Heindel JJ (2011) Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 127(3–5):204–215CrossRefGoogle Scholar
  33. Sun L, Yu T, Guo J, Zhang Z, Hu Y, Xiao X, Sun Y, Xiao H, Li J, Zhu D, Sai L, Li J (2016) The estrogenicity of methylparaben and ethylparaben at doses close to the acceptable daily intake in immature Sprague-Dawley rats. Sci Rep 6:25173CrossRefGoogle Scholar
  34. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV et al (2012) Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33(3):378–455CrossRefGoogle Scholar
  35. Vo TT, Jeung EB (2009) An evaluation of estrogenic activity of parabens using uterine calbindin-d9k gene in an immature rat model. Toxicol Sci 112(1):68–77CrossRefGoogle Scholar
  36. Vo TT, Nguyen PV, Duong HT, Nguyen TD, Huynh HT, Nong HV (2015) Potential effect of combined xenoestrogens during gestation stages on mouse offspring. J Environ Biol 36(2):337–344Google Scholar
  37. Wang L, Wu Y, Zhang W, Kannan K (2013) Characteristic profiles of urinary p-hydroxybenzoic acid and its esters (parabens) in children and adults from the United States and China. Environ Sci Technol 47(4):2069–2076CrossRefGoogle Scholar
  38. Wang L, Asimakopoulos AG, Kannan K (2015a) Accumulation of 19 environmental phenolic and xenobiotic heterocyclic aromatic compounds in human adipose tissue. Environ Int 78:45–50CrossRefGoogle Scholar
  39. Wang KH, Kao AP, Chang CC, Lin TC, Kuo TC (2015b) Bisphenol A-induced epithelial to mesenchymal transition is mediated by cyclooxygenase–2 up-regulation in human endometrial carcinoma cells. Reprod Toxicol 58:229–233CrossRefGoogle Scholar
  40. Xu Z, Liu J, Wu X, Huang B, Pan X (2017) Nonmonotonic responses to low doses of xenoestrogens: a review. Environ Res 155:199–207CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Gynecologic OncologyAntalya Training and Research HospitalAntalyaTurkey
  2. 2.Food Safety and Research InstituteAkdeniz UniversityAntalyaTurkey
  3. 3.Department of PathologyAkdeniz UniversityAntalyaTurkey
  4. 4.Department of Gynecologic OncologyAkdeniz UniversityAntalyaTurkey

Personalised recommendations